The growing popularity of weight-loss drugs is prompting food companies and restaurants to change their menus, as consumers increasingly turn to high-protein, low-calorie foods.
In this context, McDonald's is considering adding new meals that meet the needs of users of these medications.
The proposals include offering bunless burgers, egg-based meals, and a variety of grilled chicken dishes.
Sky Anderson, president of McDonald's U.S. operations, said during a meeting with investors last month that the company is considering these options, noting that "84% of U.S. households with GLP-1 drug users frequent McDonald's restaurants, and this is a golden opportunity."
These drugs include Ozempic, Mounjaro, and Wegovy, which help reduce appetite and have seen widespread use over the past three years.
McDonald's has already begun highlighting the protein content of some of its meals through labels that explain their contents, and has also reintroduced Diet Coke in its Australian branches.
This comes amid growing interest in healthy foods in Australia as well, where about 2% of the population uses GLP-1 drugs, compared to about one in ten in the United States.